Search

everythinglearnresearchcommunity

for

Search:↓

Hura crepitans and its compound daphne factor F3 may help treat hair loss by blocking a specific hair growth inhibitor.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Combining low-level laser therapy with topical corticosteroids effectively improved Lichen Planopilaris symptoms.

Genetic defects and UV radiation cause skin damage and aging.

Gene mutations can cause problems in male genital development.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Generalized pustular psoriasis patients often need strong medication and careful treatment due to flare-ups and complications.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The AUTS2 gene is linked to neurological disorders and may affect human brain development and cognition.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Finasteride helps reduce priapism in sickle cell anemia patients.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.